Global life-sciences and financial leaders bring decades of health-care, biopharma, and strategic expertise to support Agilent’s next phase of growth SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, […]
Announcing a next-generation platform for MALDI-TOF MS-based microbial identification, featuring the most extensive database that covers approximately 85,000 prokaryotic species, including not only well-known, previously described microorganisms but also hard-to-culture and uncultured microorganisms — MicrobialTrack redefines the boundaries of MALDI-TOF MS-based microbial identification. Shimadzu Corporation has launched MicrobialTrack, an innovative software platform designed for high-precision microbial identification […]
Advancing sustainable innovation in liquid chromatography SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that the Infinity III LC Series — the company’s latest liquid chromatography (LC) instruments — are the first Agilent instruments to receive the new My Green Lab® ACT® Ecolabel 2.0, further reinforcing Agilent’s commitment to sustainable scientific innovation. Designed for efficiency, […]
Empowering biopharma with seamless, high-precision workflows from biomarker discovery to targeted enrichment and protein quantification for clinical trials WASHINGTON, D.C. and ZUERICH, Switzerland – SISCAPA Assay Technologies, a global leader in high-sensitivity protein quantitation, and Biognosys, a pioneer in next-generation proteomics, today announced an exclusive strategic collaboration to offer biopharma customers a streamlined end-to-end solution for high-sensitivity […]
Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes SEOUL, South Korea — Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over […]
UPPSALA, Sweden — PeptiSystems, a biotech company specializing in innovative manufacturing solutions for peptide and oligonucleotide drugs, has formed an exclusive global partnership with Asahi Kasei Bioprocess America (AKBA), a leading provider of advanced bioprocessing equipment solutions. The collaboration combines PeptiSystems’ flow-through instrument platform with AKBA’s high-performance column technology – giving customers a streamlined and reliable setup from […]
St. Paul, Minn. – Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecules, providing comprehensive technical support to biopharmaceutical companies and contract manufacturers operating from small-scale to full […]
World-class experts from bioprocessing and cell and gene therapy (CGT) fields include Phil Vanek PhD, Carl Schoellhammer PhD, Daniel C. Smith PhD and Nick Clarkson D.Phil Bedfordshire, UK: Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, today announced the formation of its Technical Advisory Board (TAB). The group will provide […]
JPP Chromatography Ltd, a pioneering UK-based research and development company, has unveiled three groundbreaking patents set to redefine amino acid analysis. These innovations promise to transform complex diagnostic and analytical processes by introducing a simpler, more efficient methodology without compromising reliability. Traditionally, amino acid analysis (AAA) relied on a cumbersome, two-step process involving hydrindantin and […]
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques.3 MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced that its Empower™ Software now […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
